Onderzoeker
Tom Decroo
Affiliaties
- Hiv en Tuberculose (Onderzoekseenheid)
Lid
Vanaf1 okt 2021 → Heden - Seksuele Gezondheid inclusief Hiv (Onderzoekseenheid)
Lid
Vanaf13 okt 2015 → 29 jun 2017 - Hiv en Tuberculose (Onderzoekseenheid)
Lid
Vanaf1 jul 2013 → 30 sep 2021
Projecten
1 - 10 of 13
- Drug resistant tuberculosis: optimize the composition of new treatment regimens in VietnamVanaf1 jan 2023 → Heden
- Impact of diagnostic delays and short treatment regimens on outcomes of rifampicin-resistant tuberculosis patients in CameroonVanaf1 jan 2022 → Heden
- TB/NTM OnderzoeksclusterVanaf1 jan 2022 → Heden
- Nontuberculous mycobacteria pulmonary disease and tuberculosis-nontuberculous mycobacteria co-infection: Epidemiology, diagnosis, and management at a tertiary health facility in GhanaVanaf1 jan 2022 → Heden
- Alternative methodological approaches to assess longterm HIV virological and clinical outcomes in resource limited settingsVanaf27 apr 2021 → Heden
- Performance of community-based ART programmes for key populations in Nigeria and sub-Saharan AfricaVanaf1 jan 2021 → Heden
- Accurate diagnosis and effective treatment for tuberculosis retreatment patients in NigerVanaf1 jan 2021 → Heden
- Innovative diagnostic and therapeutic measures to improve MDR-TB diagnosis and management in Conakry, GuineaVanaf1 jan 2020 → Heden
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without Creating MoreVanaf1 okt 2018 → Heden
- Novel high-dose tuberclosis retreatment regimens: How to overcome resistance without creating more?Vanaf1 okt 2018 → 30 sep 2021
Publicaties
31 - 40 van 120
- How second-line injectable drugs work(2021)
Auteurs: Armand Van Deun, Tom Decroo
Pagina's: e1167-e1168 - Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?(2021)
Auteurs: Sabira Tahseen, Armand Van Deun, Bouke de Jong, Tom Decroo
Pagina's: 831-835 - Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria: a retrospective cohort study(2021)
Auteurs: Olujuwon Justin Ibiloye, Plang Jwanle, Caroline Masquillier, Sara Van Belle, Ekere Jaachi, Olubunmi Amoo, Ahmed Isah, Temiwoluwa Omole, Jay Osi Samuel, Josefien van Olmen, et al.
- Finding the right balance between efficacy and tolerability for TB treatment: the search continues(2021)
Auteurs: A.K.J. Maug, M.A. Hossain, Mourad Gumusboga, Tom Decroo, Wim Mulders, Sofie Braet, Jozefien Buyze, D A Jiménez, Céline Schurmans, Natacha Herssens, et al.
Pagina's: 84-86 - Thin-layer-agar-based direct phenotypic drug susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance otherwise missed by WHO-endorsed diagnostic tests(2021)
Auteurs: Elisa Ardizzoni, E. Ariza, D. Mulengwa, Q. Mpala, R de la Tour, Gugu Maphalala, F. Varaine, Bernhard Kerschberger, Pieter Graulus, A-L Page, et al.
- Should treatment of low-level rifampicin mono-resistant tuberculosis be different?(2021)
Auteurs: Armand Van Deun, Tom Decroo
- "I don't know when he will be back": life-changing events challenge the community ART Group model- a qualitative research study, Tete, Mozambique(2021)
Auteurs: Ivan Alejandro Pulido Tarquino, Emilie Venables, Raja Reis Simone, Jose Manuel de Amaral Fidelis, Tom Decroo
Pagina's: 1-9 - Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown(2021)
Auteurs: Armand Van Deun, Tom Decroo, Kya Jai Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Pim De Rijk, Sabira Tahseen, Bouke de Jong, Leen Rigouts
- Human rights: finding the right balance for rifampicin-resistant TB treatment(2021)
Auteurs: Armand Van Deun, A Piubello, Lut Lynen, Bouke C de Jong, Tom Decroo
Pagina's: 327-328 - High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss(2021)
Auteurs: Mahamadou Bassirou Souleymane, Alberto Piubello, Ibrahim Mamane Lawan, Souleymane Hassane-Harouna, Mourtala Mohamed Assao-Neino, Alphazazi Soumana, Zelika Hamidou-Harouna, Assiatou Gagara-Issoufou, Nimer Ortuno-Gutierrez, Alberto Roggi, et al.